Mechanistically, activation of EGFR stimulates signal transduction and activator of transcription (STAT3), which interacts with the promoter region of homeodomain-interacting protein kinase 2 (HIPK2) gene and drives the progression of AKI to CKD [106]. Here, HIPK2 is linked to chronic kidney disease.